Petros Pharmaceuticals Inc
PTPI
Get informed when a big investor buys or sells
+ FollowMarket Cap$169.49K
Close$
Share Statistics
| Market cap | $169,489.00 |
|---|---|
| Enterprise Value | $-3,319,106.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.56 |
| Beta | 1.92 |
| Outstanding Shares | 47,391,733 |
Return
| Return on Equity | 272292.17% |
|---|---|
| Return on Assets | 53824.89% |
| Return on Invested Capital | -662036.57% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data